HTA103: Evidence Based Decision Making in Healthcare

moderated by Prof Manie de Klerk and Prof Edina Sinanovic

Course Summary

In this module we will aim to assist the phrasing of focused and specific clinical questions requiring decision making, search medical literature and apply validity criteria to therapeutic,
health economic and meta-analytic research. By the end of this module, you should be able to understand critical appraisal, learn about evaluating Harm and where Guidelines fit in. You will review economic evaluations with a check list and work through some practical examples in Health Economics.


  • Part A

    Evidence Based Medicine and Critical Appraisal of Trials moderated by Prof Manie de Klerk

    In this section we will investigate what Evidence Based Medicine is and why we need it.

    • What happens when medicine is not sufficiently researched? How are clinical decisions made?
    • What are the barriers for getting good evidence?
      How do we interpret the results of the studies that were done?
    • When are the results sufficient and are they relevant within the context we need to apply it to?

    All of these questions will be investigated in this part of the course.

  • Part B

    Critical Appraisal of Economic Evaluations moderated by Prof Edina Sinanovic

    Economic evaluation of health care interventions can help inform decisions about how to apply new or existing tests, therapies, and preventive and public health interventions so that they represent a good use of resources. The user of published economic evaluation results should be made aware of the methodological issues involved in undertaking an economic evaluation of health care interventions.
    Part B of Module 3 provides course participants with an understanding of how to interpret published economic evaluation studies and assess their usefulness in policy. One of the tasks will include apprising a published economic evaluation using a checklist for assessing economic evaluations. Such a checklist is based on the basic principles of a sound economic evaluation study, and should help users to identify quickly its strengths and weaknesses.

  • Part C

    Critical Appraisal of Harm and Clinical Guidelines compiled by Dr Jacqui Miot

    In this section we investigate the harms associate with medicine in correlation with possible benefits, the process of composing clinical guidelines that are based on Evidence Based Practice and social and economic impact and work through the AGREE II tool and how to use it.

  • Dates

    6-31 May; 15 Jul-8 Aug; 26 Aug-20 Sep

  • 20 Points

    CPD accreditation

  • 20 hours

    Study time

  • Fees (excl VAT)

    R3856 Corp Members
    R4097 Stand Members
    R4338 Ind Members
    R4820 Non Members

  • No

    Webinars hosted

Meet the Contributors

Prof Manie de Klerk

Prof Manie de Klerk

Consultant in health: LIfeQ and Lecturer: MBA in Healthcare Leadership course at USB

Click on image for bio

Prof Edina Sinanovic

Prof Edina Sinanovic

Head Health Economic Division at UCT

Click on image for bio

Scheduled Events

Please note that dates, topics and presenters are subject to change.

8:30 am Virtual CPD – 28 February 2024
Virtual CPD – 28 February 2024
Feb 28 @ 8:30 am – 10:15 am
Virtual CPD - 28 February 2024
Programme 08h55: Login and sound check 09h00: The Great Irony Presented by: Dr Zeenat Moorad (Haematologist) 10h05: Wrap up Link to register Thank you to Aspen for providing the unconditional educational sponsorship, making this session…
6:30 pm Evening Virtual CPD – 28 Februar... @ Zoom - link to register available in the invitation
Evening Virtual CPD – 28 Februar... @ Zoom - link to register available in the invitation
Feb 28 @ 6:30 pm – 8:30 pm
Evening Virtual CPD - 28 February 2024 @ Zoom - link to register available in the invitation | Sandton | Gauteng | South Africa
Programme 18h55: Login and sound check 19h00: Review Narrow Therapeutic Index (NTI) Presented by: Prof Teun van Gelder (Nephrologist & Clinical Pharmacologist from the Netherlands) 20h05: Wrap up Link to register Thank you to Astellas…

Latest Newsletter

Find us on